Keyphrases
Interactive Documents
88%
Intrahepatic Cholestasis of Pregnancy
88%
Lamivudine-resistant
88%
Outpatient Endoscopy
88%
Moderate Wasting
88%
Ready-to-use Supplementary Food
88%
Metabolic Risk Factors
88%
Metabolic Obesity
88%
Liver Transplant Recipients
88%
Metabolic Dysfunction
88%
Metabolic Health
88%
Digestible Indispensable Amino Acid Score (DIAAS)
59%
Fecal-oral Transmission
44%
Extraintestinal Spread
44%
Universal Recovery
44%
Traditional Medicine Use
44%
Post-liver Transplant
44%
Patient Demographics
44%
Sarcopenic Obesity
44%
Liver Transplant Evaluation
44%
Growing Patients
44%
Operative
44%
Liver Failure
44%
Preoperative Risk Assessment
44%
Metabolic-associated Fatty Liver Disease (MAFLD)
44%
Chronic Liver Disease
44%
Anatomical Constraints
44%
Strict Control
44%
Comorbidity
44%
Alcohol Use Disorder
44%
Complications of Liver Transplantation
44%
Bariatric Surgery
44%
Liver Disease
44%
Renal Disease
44%
Immunosuppressive Therapy
44%
Cardiovascular Risk
44%
John Martin
35%
Iatrogenic Preterm Birth
29%
Dedicated Software
8%
Procedural Satisfaction
8%
Text Message Intervention
8%
Procedural Instructions
8%
Boston Bowel Preparation Score
8%
Medicine and Dentistry
Endoscopy
88%
Alternative Medicine
88%
Colonoscopy
88%
Disease
88%
Entamoeba Histolytica
88%
Herbal Medicine
88%
Amebic Infection
88%
Outpatient
88%
Percutaneous Drainage
88%
Liver Graft
88%
Intrahepatic Cholestasis of Pregnancy
88%
Traditional Medicine
71%
Pyogenic Liver Abscess
44%
Antibiotics
44%
Metronidazole
44%
Biliary Tract Disease
44%
Abscess
44%
Amoebic Liver Abscess
44%
Gastrointestinal Tract
44%
Liver Disease
44%
Malignant Neoplasm
44%
Medication Compliance
35%
Arm
35%
Logistic Regression Analysis
35%
Immunosuppressive Treatment
22%
Kidney Disorder
22%
Sarcopenic Obesity
22%
Cardiovascular Disease
22%
Alcoholic Polyneuropathy
22%
Surgical Risk
22%
Chronic Liver Disease
22%
Patient Population
22%
Liver Failure
22%
Bariatric Surgery
22%
Intestine Preparation
17%
Socioeconomic Status
17%
Allopathic Medicine
17%
Prevalence
17%
Patient with Hypertension
17%
Adenoma
8%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Lamivudine
88%
Amebic Infection
88%
Hepatitis B
88%
Intrahepatic Cholestasis
88%
Adefovir
88%
Prevalence
88%
Liver Amebiasis
44%
Pyogenic Liver Abscess
44%
Bile Acid
33%
Adverse Event
22%
Inflammation
17%
Side Effect
17%
Interferon
17%
Chronic Hepatitis B
17%
Premature Labor
11%
Ursodeoxycholic Acid
11%
Pruritus
11%
Stillbirth
11%
Metabolic Disorder
11%
Cardiovascular Disease
11%